ABBV vs PFE

AbbVie Inc. against Pfizer — live side-by-side technical comparison.

Prices as of 2026-11-06T21:01:45+00:00 UTC · updates daily

Who leads right now

ABBV leads 5 of the 5 windows we measure — over 1 month ABBV is +7.3% and PFE +5.0%; over year to date ABBV is +27.5% and PFE +18.0%. The ABBV/PFE price ratio stands at 9.9119, above its 50-day average of 9.4596, and above the 200-day average of 8.8875. A ratio above its own average means ABBV is gaining on PFE; on this reading the recent edge belongs to ABBV.

Performance side by side

ABBVPFE
Price$291.31 $29.39
1 day +1.1%lead -1.6%
5 days -1.2%lead -3.7%
1 month +7.3%lead +5.0%
6 months +42.1%lead +10.8%
Year to date +27.5%lead +18.0%
52-week position 90% of range 74% of range
52-week range $190.75–$302.93 $23.62–$31.44
vs 50-day average above $271.95 above $28.74
vs 200-day average above $238.94 above $26.91
RSI (14) 59 50
Next earnings 2026-10-302027-02-02

Where each one stands

ABBV — AbbVie Inc.

ABBV trades at $291.31, above its 50-day average of $271.95, and above the 200-day at $238.94. It sits at 90% of its 52-week range ($190.75–$302.93); 14-day RSI is 59, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $294.89 (1.2% away) and the first support below is $275.00 (5.6% down). On the checklist the page runs for every asset, 4 of 6 checks read bullish — the lean is bullish.

PFE — Pfizer

PFE trades at $29.39, above its 50-day average of $28.74, and above the 200-day at $26.91. It sits at 74% of its 52-week range ($23.62–$31.44); 14-day RSI is 50, in neutral territory; an average session moves it about 2.7%. For levels, the first level overhead is $30.00 (2.1% away) and the first support below is $29.21 (0.6% down). On the checklist the page runs for every asset, 3 of 6 checks read bullish — the lean is bullish.

Which one moves harder

Both move about the same amount day to day (2.7% and 2.7% of price), so the same position size carries comparable risk in either.

What would change the picture

The comparison turns on those levels: ABBV clearing $294.89 or losing $275.00; PFE clearing $30.00 or losing $29.21. Until one of them gives way, the relative reading above stands.

Questions people ask about ABBV vs PFE

Which is performing better right now, ABBV or PFE?
Over the past month ABBV is +7.3% and PFE is +5.0%, so ABBV is ahead on that window. Year to date the figures are +27.5% for ABBV and +18.0% for PFE.
Is ABBV or PFE more volatile?
Both move about the same amount day to day (2.7% and 2.7% of price), so the same position size carries comparable risk in either.
What are the key levels for ABBV and PFE?
ABBV: resistance $294.89, support $275.00; PFE: resistance $30.00, support $29.21. Levels come from recent swing zones and round numbers, recomputed daily.
When do ABBV and PFE report next?
ABBV: 2026-10-30. PFE: 2027-02-02. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the ABBV/PFE ratio mean?
It is simply ABBV's price divided by PFE's — 9.9119 today. When the ratio rises, ABBV is outperforming; when it falls, PFE is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

Full technical briefs

ABBV →
AbbVie Inc.
Full technical brief: trend, levels, chart, news
PFE →
Pfizer
Full technical brief: trend, levels, chart, news

Related comparisons

JNJ vs LLYABBV vs LLYLLY vs MRKLLY vs UNHLLY vs TMOAMGN vs LLYGILD vs LLYABT vs LLY